Hepatic toxicity of liposomal encapsulated doxorubicin

Lancet. 1993 Mar 20;341(8847):756. doi: 10.1016/0140-6736(93)90525-l.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications
  • Adult
  • Chemical and Drug Induced Liver Injury*
  • Doxorubicin / administration & dosage*
  • Doxorubicin / adverse effects
  • Drug Carriers
  • Humans
  • Liposomes
  • Male
  • Middle Aged
  • Sarcoma, Kaposi / drug therapy
  • Sarcoma, Kaposi / etiology

Substances

  • Drug Carriers
  • Liposomes
  • Doxorubicin